Ozanne G, Mathieu L G, Baril J P
Rev Can Biol. 1977 Dec;36(4):307-16.
In recent years, a possible relationship between pathogenicity and colicinogeny in some Escherichia coli colicin V-producing strains had been inferred. In our laboratory, we have elaborated a simple in vitro method for the production of colicin V free of large, non dialyzable macromolecules and presumably of bacterial endotoxin. This allows study of the effects of colicin V in vivo without an undesirable added physiological response of the experimental animal to endotoxin. All the Col V+ strains we have studied displayed a greater ability to survive in the peritoneal cavity of mice than the Col V- strains. Also, we have detected colicin V in peritoneal fluids of agonizing mice injected with Col V+ strains. Phagocytosis by peritoneal macrophages seemed to be inhibited in vitro in the presence of colicin V. Colicin V is not toxic in vivo in low concentration, after intraperitoneal or intravenous injection but it may favor the multiplication and the invasiveness of the strains that produce it.
近年来,已经推断出在一些产大肠杆菌素V的菌株中致病性与产大肠杆菌素能力之间可能存在关系。在我们实验室,我们已经精心设计了一种简单的体外方法来生产不含大的、不可透析的大分子且可能不含细菌内毒素的大肠杆菌素V。这使得能够在不使实验动物对内毒素产生不良附加生理反应的情况下研究大肠杆菌素V在体内的作用。我们研究的所有Col V+菌株在小鼠腹腔中的存活能力都比Col V-菌株更强。此外,我们在注射了Col V+菌株的濒死小鼠的腹水中检测到了大肠杆菌素V。在大肠杆菌素V存在的情况下,体外腹膜巨噬细胞的吞噬作用似乎受到抑制。腹腔内或静脉注射后,低浓度的大肠杆菌素V在体内无毒,但它可能有利于产生它的菌株的繁殖和侵袭性。